Figure 2.
Figure 2. EFS according to the amount of BCL2/IgH+ cells. EFS was calculated according to RQ-PCR results obtained at diagnosis on BM (A) or PB (B) samples. High and low/intermediate refer to patients with more or fewer than 1 BCL2/IgH+ cell in 102 normal cells. Patients with a low or intermediate amount of disease were combined in the EFS analysis because their clinical outcome was very similar (53% and 65%, respectively; P = .47).

EFS according to the amount of BCL2/IgH+ cells. EFS was calculated according to RQ-PCR results obtained at diagnosis on BM (A) or PB (B) samples. High and low/intermediate refer to patients with more or fewer than 1 BCL2/IgH+ cell in 102 normal cells. Patients with a low or intermediate amount of disease were combined in the EFS analysis because their clinical outcome was very similar (53% and 65%, respectively; P = .47).

Close Modal

or Create an Account

Close Modal
Close Modal